Increased expression of HMG-CoA reductase has been associated with poor prognosis; in addition, a higher expression of this enzyme has been noted in enzalutamide-resistant PCa cells, and its knockout can restore enzalutamide sensitivity. Here, HMGCR is linked to posterior cortical atrophy.